Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Rapid Micro Biosystems, Inc. (RPID)

1.8997   0.02 (1.05%) 12-06 10:12
Open: 1.85 Pre. Close: 1.88
High: 1.8999 Low: 1.79
Volume: 11,278 Market Cap: 69(M)

Technical analysis

as of: 2022-12-06 9:50:53 AM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 2.91     One year: 3.56
Support: Support1: 1.6    Support2: 1.33
Resistance: Resistance1: 2.49    Resistance2: 3.04
Pivot: 2.15
Moving Average: MA(5): 1.85     MA(20): 2.23
MA(100): 3.31     MA(250): 5.07
MACD: MACD(12,26): -0.3     Signal(9): -0.3
Stochastic oscillator: %K(14,3): 24.7     %D(3): 16.3
RSI: RSI(14): 34
52-week: High: 12.43  Low: 1.6
Average Vol(K): 3-Month: 25 (K)  10-Days: 34 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ RPID ] has closed above bottom band by 23.4%. Bollinger Bands are 26.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.95 - 1.96 1.96 - 1.97
Low: 1.77 - 1.78 1.78 - 1.79
Close: 1.86 - 1.88 1.88 - 1.9

Company Description

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

Headline News

Thu, 01 Dec 2022
Healthcare Stocks Moving Thursday: VAPO, KTRA, ONCY, RMED, SQZ, BDSX, CGTX, RPID - InvestorsObserver

Thu, 01 Dec 2022
Scotland's new Ag Bill: Union confident its vision is both simple and deliverable - The Scottish Farmer

Wed, 30 Nov 2022
Should You Buy Rapid Micro Biosystems Inc (RPID) Stock on Wednesday? - InvestorsObserver

Thu, 10 Nov 2022
Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Tops Revenue Estimates - Nasdaq

Mon, 10 Oct 2022
Rapid Micro Biosystems Announces RMBNucleus™ Mold Alarm for the Growth Direct® System - GlobeNewswire

Mon, 12 Sep 2022
Rapid Micro Biosystems CEO Rob Spignesi to Speak at the 2022 PDA/FDA Joint Regulatory Conference - GlobeNewswire

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 36 (M)
Shares Float 14 (M)
% Held by Insiders 13.7 (%)
% Held by Institutions 82.5 (%)
Shares Short 227 (K)
Shares Short P.Month 310 (K)

Stock Financials

EPS 0.12
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 4.26
Profit Margin (%) 0
Operating Margin (%) -330.7
Return on Assets (ttm) -16.3
Return on Equity (ttm) -28.5
Qtrly Rev. Growth -31.3
Gross Profit (p.s.) -0.22
Sales Per Share 0.49
EBITDA (p.s.) -1.58
Qtrly Earnings Growth 0
Operating Cash Flow -60 (M)
Levered Free Cash Flow -48 (M)

Stock Valuations

PE Ratio 14.53
PEG Ratio 0
Price to Book value 0.44
Price to Sales 3.83
Price to Cash Flow -1.16

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.